Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Appl Mater Interfaces ; 13(48): 57230-57240, 2021 Dec 08.
Article in English | MEDLINE | ID: mdl-34841847

ABSTRACT

The design of artificial photocatalytic devices that simulates the ingenious and efficient photosynthetic systems in nature is promising. Herein, a metal-organic cage [Pd6(NPyCzPF)12]12+ (MOC-PC6) integrating 12 organic ligands NPyCzBP and 6 Pd2+ catalytic centers is designed, which is well defined to include organic dye fluorescein (FL) for constructing a supramolecular photochemical molecular device (SPMD) FL@MOC-PC6. Photoinduced electron transfer (PET) between MOC-PC6 and the encapsulated FL has been observed by steady-state and time-resolved emission spectroscopy. FL@MOC-PC6 is successfully heterogenized with TiO2 by a facile sol-gel method to achieve a robust heterogeneous FL@MOC-PC6-TiO2. The close proximity between the Pd2+ catalytic site and FL included in the cage enables PET from the photoexcited FL to Pd2+ sites through a powerful intramolecular pathway. The photocatalytic hydrogen production assessments of the optimized 4 wt % FL@MOC-PC6-TiO2 demonstrate an initial H2 production rate of 2402 µmol g-1 h-1 and a turnover number of 4356 within 40 h, enhanced by 15-fold over that of a homogeneous FL@MOC-PC6. The effect of the MOC content on photocatalytic H2 evolution (PHE) is investigated and the inefficient comparison systems, such as MOC-PC6, MOC-PC6-TiO2, FL-sensitized MOC-PC6/FL-TiO2, and analogue FL/MOC-PC6-TiO2 with free FL, are evaluated. This study provides a creative and distinctive approach for the design and preparation of novel heterogeneous SPMD catalysts based on MOCs.

2.
ACS Appl Mater Interfaces ; 13(22): 25960-25971, 2021 Jun 09.
Article in English | MEDLINE | ID: mdl-34036785

ABSTRACT

The development of artificial devices that mimic the highly efficient and ingenious photosystems in nature is worthy of in-depth study. A metal-organic cage (MOC) Pd2(M-4)4(BF4)4, denoted as MOC-Q1, integrating four organic photosensitized ligands M-4 and two Pd2+ catalytic centers is designed for a photochemical molecular device (PMD). MOC-Q1 is successfully immobilized on graphitic carbon nitride (g-C3N4) by hydrogen bonds to obtain a robust heterogeneous direct Z-scheme g-C3N4/MOC-Q1 photocatalyst for H2 generation under visible light. The optimized g-C3N4/MOC-Q1 (2 wt %) system shows high hydrogen evolution activity (4495 µmol g-1 h-1 based on the catalyst mass) and exhibits stable performances for 25 h (a turnover number of 19,268 based on MOC-Q1), significantly outperforming pure MOC-Q1, g-C3N4, and comparsion materials Pd/g-C3N4/M-4, which is the highest one of all reported heterogeneous MOC-based photocatalysts under visible irradiation. This enhancement can be ascribed to the synergistic effects of high-efficient electron transfer, extended visible-light response region, and good protective environment for MOC-Q1 arising from an efficient direct Z-scheme heterostructure of g-C3N4/MOC-Q1. This rationally designed and synthesized MOC/g-C3N4-based heterogeneous PMD is expected to have great potential in photocatalytic water splitting.

3.
Chemistry ; 26(43): 9466-9470, 2020 Aug 03.
Article in English | MEDLINE | ID: mdl-32259330

ABSTRACT

Macrocycle, cyclo[4] [(1,3-(4,6)-dimethylbezene)[4](2,6-(3,5)-dimethylpyridine (B4P4), shows highly selective binding affinity with protirelin (Pyr-His-Pro-NH2 ; TRH) among the tested 26 drug or drug adductive substrates. The stable complexation in a 1:1 manner was fully characterized in solution, gas phase, and solid state study. Furthermore, B4P4 acts as an efficient TRH inhibitor even at [macrocycle]:[drug] <1:300, both in membrane transport and cellar incubation. The current work provides an unprecedented strategy for macrocycles to be efficiently used in drug target therapy.


Subject(s)
Dipeptides/chemistry , Pyridines/chemistry , Thyrotropin-Releasing Hormone/pharmacology , Dipeptides/metabolism , Thyrotropin-Releasing Hormone/chemistry , Thyrotropin-Releasing Hormone/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...